Back to Search
Start Over
Observer agreement of treatment responses on planar bone scintigraphy in prostate cancer patients: importance of the lesion assessment method
- Source :
- Fonager, R F, Zacho, H D, Albertsen, S, Fledelius, J, Ejlersen, J A, Christensen, M H, Aleksyniene, R, Biurrun Manresa, J A & Petersen, L J 2016, ' Observer agreement of treatment responses on planar bone scintigraphy in prostate cancer patients : importance of the lesion assessment method ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 43, no. Suppl. 1, OP350, pp. s108 . < http://link.springer.com/journal/259/43/1/suppl/page/1 >, Fonager, R F, Zacho, H D, Albertsen, S, Fledelius, J, Ejlersen, J A, Christensen, M H, Aleksyniene, R, Biurrun Manresa, J A & Petersen, L J 2017, ' Observer agreement of treatment responses on planar bone scintigraphy in prostate cancer patients : importance of the lesion assessment method ', Nuclear Medicine Communications, vol. 38, no. 3, pp. 215-221 . https://doi.org/10.1097/MNM.0000000000000643
- Publication Year :
- 2017
-
Abstract
- Purpose The aim of this study was to assess observer agreement on the evaluation of treatment responses of bone metastases by bone scintigraphy (BS) using different scoring methods in prostate cancer patients. Patients and methods Sixty-three paired BS from 55 patients were included. BS was performed before and after more than 12 weeks of anticancer treatment. A panel of experienced nuclear medicine physicians from several institutions evaluated treatment response using three different methods: (a) standard clinical assessment, (b) MD Anderson criteria, and (c) Prostate Cancer Working Group 2 (PCWG-2) criteria. All methods were based on the evaluation of paired before-after bone scans. Results Readers were able to classify the presence of bone metastases at baseline with a high level of agreement [Cohen's κ=0.94, 95% confidence interval (CI) 0.82-1.00]. Observer agreement on bone response by PCWG-2 criteria showed considerable agreement (Cohen's κ=0.84, 95% CI: 0.69-0.99). Evaluation using standard clinical assessment and MD Anderson criteria showed moderate agreement (0.52, 95% CI: 0.36-0.69 and 0.64, 95% CI: 0.48-0.79, respectively). There was considerable variation among readers for regional lesion count on individual scans, with limits of agreement of -10 to 10 lesions or more for the majority of anatomical regions, including the thorax, spine, and pelvis. Conclusion Observer agreement on treatment response by BS varied notably across methods. Optimal agreement was achieved by the PCWG-2 criteria. Variation in the classification of treatment response of bone metastases may have a significant impact on clinical decision-making, emphasizing the need for a uniform approach, including during clinical practice. Response assessment by lesion counting on repeated BS without access to previous scans cannot be recommended. Fil: Fonager, Randi F.. Aalborg University; Dinamarca Fil: Zacho, Helle D.. Aalborg University; Dinamarca Fil: Albertsen, Signe. Aalborg University; Dinamarca Fil: Fledelius, Joan. Herning Hospital; Dinamarca Fil: Ejlersen, June A.. Herning Hospital; Dinamarca Fil: Christensen, Mette H.. Viborg Regional Hospital; Dinamarca Fil: Aleksyniene, Ramune. Aalborg University; Dinamarca Fil: Biurrun Manresa, José Alberto. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Aalborg University; Dinamarca Fil: Petersen, Lars J.. Viborg Regional Hospital; Dinamarca
- Subjects :
- Thorax
Male
medicine.medical_specialty
CIENCIAS MÉDICAS Y DE LA SALUD
Observer (quantum physics)
Bone Neoplasms
Medicina Clínica
PROSTATE CANCER
Bone and Bones
030218 nuclear medicine & medical imaging
Lesion
03 medical and health sciences
Prostate cancer
0302 clinical medicine
BONE SCAN
medicine
Humans
Radiology, Nuclear Medicine and imaging
Radiología, Medicina Nuclear y Diagnóstico por Imágenes
Pelvis
Aged
Aged, 80 and over
Observer Variation
BONE METASTASES
medicine.diagnostic_test
business.industry
Prostatic Neoplasms
General Medicine
Middle Aged
medicine.disease
Confidence interval
Response assessment
medicine.anatomical_structure
Treatment Outcome
OBSERVER AGREEMENT
Bone scintigraphy
030220 oncology & carcinogenesis
Radiology
medicine.symptom
business
Nuclear medicine
RESPONSE ASSESSMENT
Subjects
Details
- ISSN :
- 14735628
- Volume :
- 38
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Nuclear medicine communications
- Accession number :
- edsair.doi.dedup.....68273d0effa0bbb1e03f26bb4a98e3e5
- Full Text :
- https://doi.org/10.1097/MNM.0000000000000643